...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors.
【24h】

Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors.

机译:作为GABA吸收抑制剂的2-取代的4-羟基丁酰胺的新衍生物的合成和生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

This study presents the synthesis of novel substituted 4-hydroxybutanamides and their influence on the activity of murine GABA transport proteins GAT1-GAT4. The active compounds, derivatives of N-arylalkyl-2-(4-diphenylmethylpiperazin-1-yl)-4-hydroxybutyramide, are characterized by pIC(50) values in range of 3.92-5.06 and by slight subtype-selectivity. Among them N-4-chlorobenzylamide was the most potent GAT inhibitor (mGAT3), while N-benzylamide was the most active in GAT1-binding assay (pK(i) = 4.96). The results pointed out that benzhydryl and benzylamide moieties are crucial for the activity of this class of compounds as murine GAT inhibitors.
机译:这项研究提出了新型取代的4-羟基丁酰胺的合成及其对鼠GABA转运蛋白GAT1-GAT4活性的影响。 N-芳基烷基-2-(4-二苯基甲基哌嗪-1-基)-4-羟基丁酰胺的活性化合物的衍生物的特征在于pIC(50)值在3.92-5.06范围内,并具有轻微的亚型选择性。其中N-4-氯苄基酰胺是最有效的GAT抑制剂(mGAT3),而N-苄基酰胺在GAT1结合测定中最活跃(pK(i)= 4.96)。结果指出,苯甲基和苄基酰胺部分对于这类化合物作为鼠类GAT抑制剂的活性至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号